Kyntra Bio (KYNB) Accumulated Depreciation & Amortization (2016 - 2023)
Historic Accumulated Depreciation & Amortization for Kyntra Bio (KYNB) over the last 10 years, with Q4 2023 value amounting to $113.0 million.
- Kyntra Bio's Accumulated Depreciation & Amortization fell 1222.0% to $113.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $113.0 million, marking a year-over-year decrease of 1222.0%. This contributed to the annual value of $113.0 million for FY2023, which is 1222.0% down from last year.
- According to the latest figures from Q4 2023, Kyntra Bio's Accumulated Depreciation & Amortization is $113.0 million, which was down 1222.0% from $128.7 million recorded in Q4 2022.
- In the past 5 years, Kyntra Bio's Accumulated Depreciation & Amortization registered a high of $128.7 million during Q4 2022, and its lowest value of $93.2 million during Q1 2019.
- In the last 5 years, Kyntra Bio's Accumulated Depreciation & Amortization had a median value of $109.4 million in 2020 and averaged $109.0 million.
- As far as peak fluctuations go, Kyntra Bio's Accumulated Depreciation & Amortization soared by 5393.49% in 2019, and later plummeted by 1222.0% in 2023.
- Over the past 5 years, Kyntra Bio's Accumulated Depreciation & Amortization (Quarter) stood at $100.4 million in 2019, then rose by 10.84% to $111.2 million in 2020, then increased by 8.77% to $121.0 million in 2021, then grew by 6.34% to $128.7 million in 2022, then dropped by 12.22% to $113.0 million in 2023.
- Its last three reported values are $113.0 million in Q4 2023, $128.7 million for Q4 2022, and $121.0 million during Q4 2021.